Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

XBIO holding history

Xenetic Biosciences, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XBIO overviewAll 13F holders of XBIOFull Q2 2026 holdings

Shares (Q2 2026)
150
Value
$437
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of XBIO by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026150$437<0.1%+150NewHolders
Q1 20260$00.0%−3−100.0%Sold outHolders
Q4 20253$7<0.1%−1−25.0%ReducedHolders
Q3 20254$12<0.1%00.0%UnchangedHolders
Q2 20254$16<0.1%00.0%UnchangedHolders
Q1 20254$11<0.1%+3+300.0%AddedHolders
Q4 20241$4<0.1%00.0%UnchangedHolders
Q3 20241$4<0.1%00.0%UnchangedHolders
Q2 20241$4<0.1%00.0%UnchangedHolders
Q1 20241$4<0.1%00.0%UnchangedHolders
Q4 20231$3<0.1%−294−99.7%ReducedHolders
Q3 2023295$1.45K<0.1%00.0%UnchangedHolders
Q2 2023295$967<0.1%00.0%UnchangedConverted for a 1-for-10 splitHolders
Q1 20232,952$1.20K<0.1%−3,017−50.5%ReducedHolders
Q4 20225,969$1.70K<0.1%+17+0.3%AddedHolders
Q3 20225,952$4.00K<0.1%−6,702−53.0%ReducedHolders
Q2 202212,654$10.0K<0.1%−11−0.1%ReducedHolders
Q1 202212,665$13.0K<0.1%+11+0.1%AddedHolders
Q4 202112,654$16.0K<0.1%+7,477+144.4%AddedHolders
Q3 20215,177$11.0K<0.1%+2,916+129.0%AddedHolders
Q2 20212,261$5.00K<0.1%00.0%UnchangedHolders
Q1 20212,261$5.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.